Cross-border settlement for nutraceutical and supplement brands with a Cyprus company

Our process begins by mapping your entire corporate structure and the intended flow of funds. We identify where and why money needs to move between your entities, whether for supplier payments, profit repatriation, or intercompany transfers. For a Cyprus supplement business, this might involve settling processor acquiring in USD and moving it to a EUR-denominated treasury account in Cyprus.

Based on this map, we select appropriate financial institution types. This could involve introducing your Cyprus company to an EEA-licensed payment institution for EUR settlement and a separate international bank for USD transfers. We ensure the chosen providers are comfortable with the nutraceutical industry's risk profile, including subscription billing models.

Next, we review your intercompany agreements and supporting documents to ensure they are ready for institutional scrutiny. Underwriters need to see a clear, logical basis for the fund flows, which we codify in your file. Finally, we make formal introductions to the selected institutions and manage the application process, ensuring that both ends of each settlement corridor are established for smooth, uninterrupted transfers.

Compliance and underwriting teams at banks and payment institutions conduct thorough due diligence on supplement businesses. They first analyse your corporate group chart to understand the ownership structure and the relationship between each legal entity. They will require all incorporation documents for your Cyprus company and any affiliated entities involved in the settlement chain.

Underwriters will scrutinise the commercial rationale for each proposed transfer. An intercompany loan agreement, service agreement, or dividend declaration must support the movement of funds. They will assess the logic, frequency, and anticipated volumes of these transfers. For a Cyprus entity, they verify its tax residency and the substance supporting it, such as local management and control.

The product itself is also under review. They will ask for ingredient lists, evidence of product registration where applicable, and samples of your marketing materials. They check for unsubstantiated health claims or billing practices like negative-option trials that can lead to high chargeback rates. We ensure your file presents this information clearly, pre-empting underwriter concerns.

Using a Cyprus company for your supplement business has specific implications for banking and settlement. The Central Bank of Cyprus and CySEC oversee the financial landscape, and local banks are diligent, particularly regarding ultimate beneficial ownership (UBO) and corporate substance. To secure reliable local banking, your company must demonstrate genuine management and control from within Cyprus.

For cross-border settlement, Cyprus's EU membership is an advantage, providing access to the SEPA network for efficient EUR transfers via local banks or EEA-licensed EMIs. However, many supplement businesses operate in USD and other currencies. This often necessitates complementing a Cyprus bank account with accounts at international banks or specialist payment institutions comfortable with the industry. Compared to a jurisdiction like Malta, Cyprus offers a similar EU-based operating environment but with its own distinct banking culture and substance requirements.

All Cyprus companies must prepare and file audited annual accounts and maintain a UBO register, both of which are required during bank onboarding. We ensure your corporate documentation, from the memorandum and articles to shareholder certificates, is complete and organised for review.

Settlement applications for supplement merchants are often rejected for reasons that a well-prepared file can prevent. A primary cause for decline is an unclear or illogical group structure. If an underwriter cannot understand why funds need to move from a US entity to a Cyprus entity, they will refuse the relationship. We prevent this by creating a clear diagram of your corporate structure and a written explanation of the commercial purpose of each entity and transfer corridor.

Another major red flag is a perceived lack of substance in the jurisdiction of incorporation. An application from a Cyprus company with no local directors, no office, and no clear connection to the island is likely to be seen as a shell company and denied. We advise on appropriate substance levels to meet bank requirements.

Finally, issues with the product or business model itself can lead to rejection. Aggressive marketing with unproven health claims, billing models that generate high chargebacks (like continuity billing), or missing product registrations are common deal-breakers. Our process vets your business model and documentation, ensuring that ingredient lists are clear, marketing is compliant, and your billing flow is transparent, thereby presenting your business as a low-risk, compliant partner.

For a Cyprus-based supplement company, establishing a full cross-border settlement corridor typically takes between three and eight weeks. This timeline covers the entire process, from the initial mapping of your payment flows to the activation of accounts at both ends of a transfer route. The exact duration depends on the complexity of your structure and the specific requirements of the chosen financial institutions.

Onboarding involves submitting the prepared file, which includes corporate documents, UBO verification, business model information, and the rationale for the accounts. You should anticipate detailed questions from the institution's compliance team, which we help you answer.

Staying live requires ongoing compliance. Financial institutions conduct periodic reviews, and they will freeze accounts if they see activity that does not match the initial application. This includes unexpected transaction volumes, payments to or from un-declared third parties, or changes in your corporate structure. We help you establish protocols for communicating any such business changes to your financial partners, ensuring your settlement facilities remain stable and operational long-term.